IRD
Opus Genetics, Inc.
Opus Genetics, Inc. (IRD) has 21 SEC Form 4 filings (21 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jul 27, 2026.
The most active filer is Chief Executive Officer Magrath George with 3 filings. Insiders have net sold $7.8M over the trailing 6 months.
- Industry:Biotechnology
- CEO:George Magrath
- Employees:18
- HQ:Durham, MI, US
- IPO:2015-01-19
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.8M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$272.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Gagnon Robert E.First in 3 months | Chief Financial Officer | Sale | 7,783 | $23K | Jul 27 | SEC ↗ |
Magrath GeorgeFirst in 3 months | Chief Executive Officer | Sale | 9,475 | $28K | Jul 27 | SEC ↗ |
SCHACHLE JOSEPH KFirst in 3 months | Chief Operating Officer | Sale | 4,644 | $14K | Jul 27 | SEC ↗ |
YERXA BENJAMIN RFirst in 3 months | President | Sale | 7,429 | $22K | Jul 27 | SEC ↗ |
| See Remarks | Sale | 1,700,000 | $7.4M | May 20 | SEC ↗ | |
| Chief Scientific & Dev. Ofc. | Sale | 7,542 | $39K | Apr 27 | SEC ↗ | |
YERXA BENJAMIN RFirst filing | President | Sale | 7,470 | $39K | Apr 27 | SEC ↗ |
Gagnon Robert E.First filing | Chief Financial Officer | Sale | 7,842 | $41K | Apr 27 | SEC ↗ |
Zaremba Rabourn AmyFirst filing | Head of Fin. Quality Assurance | Sale | 1,641 | $9K | Apr 27 | SEC ↗ |
| Chief Executive Officer | Sale | 9,511 | $50K | Apr 27 | SEC ↗ | |
| Chief Operating Officer | Sale | 4,697 | $25K | Apr 27 | SEC ↗ | |
Jayagopal AshwathFirst filing | Chief Scientific & Dev. Ofc. | Sale | 3,719 | $19K | Mar 18 | SEC ↗ |
Magrath GeorgeFirst filing | Chief Executive Officer | Sale | 24,438 | $127K | Mar 18 | SEC ↗ |
SCHACHLE JOSEPH KFirst filing | Chief Operating Officer | Sale | 3,719 | $20K | Mar 18 | SEC ↗ |
Related companies
Opus Genetics, Inc. is in the Healthcare sector.